Welcome To IANS Live - NATION - Hetero's Covid-19 oral drug gets WHO pre-qualification

This is the first pre-qualification for a generic version of Pfizer's Covid-19 oral antiviral drug 'Paxlovid', which the WHO called, the best therapeutic choice for high-risk patients to date.WHO

Related Keywords

Hyderabad ,Andhra Pradesh ,India ,Charles Gore ,Vamsi Krishna Bandi ,Pfizer ,Hetero Group Of Companies ,World Health Organization Prequalification Of Medicines Programme ,World Health Organization Prequalification ,Medicines Programme ,Managing Director ,Hetero Group ,Medicines Patent Pool ,Middle Income Countries ,Executive Director ,Emergency Use Authorization ,Drugs Controller General ,Nirmatrelvir ,Ritonavir ,Hetero ,Nirmacom ,Patients ,Available ,Generic ,Version ,Pfizers ,Director ,